In short
The episode “The Engineers: Exploring the Human” (BBC World Service) focuses on three engineering breakthroughs in biomedicine: brain-computer interfaces, targeted drug delivery using ultrasound-activated bubbles, and ingestible electronics that stimulate gut-to-brain neural pathways.
Guests
Tom Oxley (Australia) is a neural engineer and founding CEO of Synchron; his stentrode brain-computer interface has been implanted in 10 patients worldwide and received approval for human trials of a permanently implanted device. He describes a non-invasive “back door” approach via the superior sagittal sinus using a catheter through the jugular vein, enabling cursor/selection control after training.
Eleanor Stride (UK, Oxford) is a biomaterials professor developing bubble drug delivery; her bubbles (about 1/50th hair width) are ultrasound-triggered to release drugs at target sites. She is adding oxygen to bubbles to help treat oxygen-starved tumors.
Khalil Ramadi (UAE, NYU; Ramadi Lab in Abu Dhabi) develops an electrocuticle pill (Flash) that delivers micro electrical “nudges” from the gut to the brain; it uses electrodes around a swallowable capsule and was inspired by a thorny lizard’s water-wicking skin. He cites ghrelin increases in early experiments.
Key claims/examples
- Bubbles can improve delivery efficiency because <1% of conventional drugs reach target sites.
- Stentrode translates brain activity into commands for Bluetooth devices; a new HID profile supports brain control.
- Gut stimulation avoids skull holes by targeting the “little brain” (enteric nervous system).
- Oxygen-in-bubbles is difficult because oxygen leaks; they changed coatings and partially substituted gases.
- Flash aims at conditions spanning appetite/metabolism/immune pathways (e.g., obesity, diabetes, inflammation), and retrieval/edibility is a future goal.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Chapters
Tap a time to open that second in VOThe Future of Medical Engineering
0:54 to 2:12
Discussion on how engineering innovations are changing medicine, including neural pathways and drug delivery.
“I'm Caroline Steele and welcome to the Engineers Exploring the Human.”
Meet the Engineers
2:12 to 3:16
Introduction of three engineers leading advancements in biomedicine: Tom Oxley, Eleanor Stride, and Khalil Ramadi.
“Thanks to our three world-leading engineers, these scenarios are becoming new realities.”
Eleanor Stride's Journey
3:16 to 4:04
Eleanor discusses her unconventional path to biomedicine and her research on bubbles in drug delivery.
“You've had a somewhat unconventional route.”
Khalil Ramadi on Gut-Brain Engineering
4:04 to 6:01
Khalil explains his focus on the gut's neurons and how they can influence brain function.
“Khalil, your interest in engineering the brain led you to look at the gut.”
Tom Oxley's Brain-Computer Interface
6:01 to 10:41
Tom talks about his work on brain-computer interfaces and the inspiration from a locked-in syndrome patient.
“We swallow pills every day for therapeutic purposes, and those pills basically come into contact with the gut lining, which has all the neurons.”
Innovations in Drug Delivery
10:41 to 14:00
Eleanor describes her method of using bubbles for targeted drug delivery and the efficiency of this approach.
“How do you do that in a not very invasive way?”
Understanding Ghrelin and the Flash Device
14:00 to 17:00
Learn about the hormone ghrelin and the innovative pill device designed to stimulate it.
“and then we looked at blood levels of different GI hormones.”
Nature-Inspired Solutions for Electrical Stimulation
17:00 to 19:35
Discover how the thorny lizard's water-wicking ability inspired a solution for a bioengineering challenge.
“And Eleanor, you were tasked with including oxygen in the bubbles which you're using to deliver drugs.”
Challenges in Delivering Oxygen to Tumor Cells
19:35 to 22:26
Explore the difficulties of delivering oxygen to cancer cells and how it impacts treatment.
“How does that device record brain activity?”
Audience Questions on Bioengineering Innovations
22:26 to 24:32
Hear audience inquiries about the applications and challenges of bioengineering technologies.
“So right now, most of the electronics that we have are very much inorganic materials that don't necessarily degrade very well in the body, and essentially you either have to retrieve them or flush them down the toilet.”
Show all 23 chapters
Future Applications of Bioengineering
24:34 to 28:03
Discuss the future of bioengineering, including human trials and potential treatments.
“Before Achilles found glory and Odysseus eventually found his way home, someone had to compose the Iliad and Odyssey.”
Understanding the Gut and Its Functions
28:03 to 28:45
Learn about the complexities of gut function and its relationship to various diseases.
“If you go a little bit further down in the gut, you get to the small intestine.”
Exploring Stentrode's Potential Applications
28:45 to 30:54
Discover the future possibilities of stentrode technology beyond locked-in syndrome.
“Tom, so far we've focused on how stentrode can help with conditions like locked-in syndrome.”
Addressing Antimicrobial Resistance with Bubbles
30:54 to 32:01
Explore how bubble technology could combat antimicrobial resistance in medicine.
“So maybe you're having small emotional reactions and the technology is reacting around you.”
Ethical Considerations in Brain-Computer Interfaces
32:01 to 36:29
Examine the ethical concerns surrounding brain-computer interface technology.
“How do you deal with those ethical concerns?”
Discrimination and Technological Augmentation
36:29 to 37:21
Discuss potential societal impacts of technology-induced discrimination and class division.
“Could you tell me a little bit more about that concern?”
AI's Role in Medical Research and Practice
37:21 to 40:38
Learn about the positive and negative impacts of AI in medical diagnostics and research.
“How would you feel if your pill went on to be used as an appetite suppressant, as something to help people lose weight as its primary function?”
Collaborative Innovations in Medicine
40:38 to 41:41
Explore the potential for collaboration across different medical technologies.
“So we'll start with the man over here in the aisle and then afterwards we'll go to the lady at the back.”
What Happens to Unused Drug Bubbles?
41:41 to 42:00
Understand the fate of drug-loaded bubbles that don't burst during treatment.
“So most of the projects that we embark on start off with what is a problem that is currently underserved or where there is an opportunity to have an impact.”
The Science of Drug Delivery Systems
42:00 to 44:05
Learn about how drug delivery systems work and the challenges faced in targeting organs.
“What happens to the bubbles and the drugs inside them that aren't burst when they're targeted at the target organ?”
Neural Implants and Their Potential
44:05 to 46:18
Discover the potential uses of neural implants in diagnostics and VR gaming.
“This is quite a lighthearted question, but could you use neural implants to do more realistic VR gaming?”
Safety and Innovations in Energy Sources
46:18 to 48:37
Explore the innovations in powering medical devices and the safety implications.
“The catch there is that if you take the energy out of a contraction, then the contraction doesn't actually do its effect.”
Future of Brain-Computer Interfaces
48:37 to 50:37
Discuss the future implications of brain-computer interfaces on human cognition.
“I think that also opens the door towards active manipulation as opposed to just source manufacturing manipulation.”
Transcript
Automatic transcript. May contain errors.0:00This BBC podcast is supported by ads outside the UK.
0:30an award-winning behavioural scientist and author of the best-selling book, How to Change, as she shares true stories from Nobel laureates, authors, athletes and everyday people about why we make the choices we do and how to make better ones to help avoid costly mistakes. Listen to Choiceology at schwab.com slash podcast or wherever you listen.
0:53Hello, you're listening to the documentary from the BBC World Service. I'm Caroline Steele and welcome to the Engineers Exploring the Human. Engineering is changing medicine. In neuroscience, brain implants are translating thoughts into words. In medication, a new technology may deliver drugs to targeted areas of the body via bubbles in the bloodstream. Meanwhile, ingestible electronics are being made to fight disease with signals from the gut. To find out more, we went to the Royal Geographical Society in London and with our partners, the Royal Commission 1851, we brought together three world-leading pioneers who are navigating the body in new ways and breaking fresh ground in biomedicine.
1:35And to help us explore the work of these fascinating engineers, we were joined by a live audience.
1:46Thank you. Surgery can be invasive. Pills are a blunt tool. But what if we could borrow the body's neural pathways and electrically nudge its response to MS or diabetes? And what if we could guide drugs through our veins to deliver them to exactly where they're needed? Paralysis can leave some people with locked-in syndrome, where they can't communicate. What if there was a non-invasive way to turn their thoughts into words? Thanks to our three world-leading engineers, these scenarios are becoming new realities. Tom Oxley, originally from Australia, is a neural engineer and professorial fellow at Melbourne Medical School.
2:23He is also founding CEO of Synchron, which has successfully implanted brain-computer interfaces in 10 patients worldwide. Eleanor Stride is from the UK. She is Professor of Biomaterials at the University of Oxford, specialising in the creation of tiny devices for targeted drug delivery. Her innovation of delivering drugs via bubbles in the bloodstream is going to human trials later this year. Khalil Ramadi is from the United Arab Emirates. He is Assistant Professor of Bioengineering at New York University. His electrocuticle pill, designed to deliver nudges from the gut to the brain, is being developed at his Ramadi Lab for Advanced Neuroengineering and Translational Medicine in Abu Dhabi.
3:04Please do join me in welcoming them all.
3:16Eleanor, let's start with you first. You've had a somewhat unconventional route. into biomedicine, right? You studied art and ended up going into engineering and studying engineering at university. You ended up ultimately looking at the physics of bubbles. How did you get there? I was doing ultrasound imaging, but actually of oil pipes, because I was working for British Maritime Technology as an intern at the time. Pure luck. New head of radiology came looking for physicists who understood ultrasound. So bubbles are used in ultrasound imaging. They're injected into your bloodstream. They make the images better because they reflect the ultrasound much more strongly than blood cells.
3:52So you can see where blood is flowing. But they were a little bit worried about safety because as many people I'm sure know, if you put bubbles into the blood stream, it can be very, very bad news. So that became my PhD. And I'm still playing with bubbles X years later. Thank you. Khalil, your interest in engineering the brain led you to look at the gut. Some people might find that jump surprising. I understand where that comes from. You know, We traditionally think about the brain as being this organ that is completely encapsulated by the skull. But we obviously have neurons pretty much everywhere in our body.
4:27They innervate most of the tissues that we have. And to your point, Caroline, actually, it was really interesting. I spent five years of my PhD trying to basically make brain implants. Not as elegant as the one Tom is going to tell us about later. But making implants as small as possible. Just to give you a bit of a sense, our current brain implants are kind of the size of a chopstick, pretty big. And so we were really focusing on trying to make them smaller. And so we managed to get them down to about the size of a hair. And at that point, I had two conversations that really sort of nudged us in this direction.
4:59The first was with patients who very understandably said, I don't care how small you make it. If it needs a hole in my skull, I don't want it. And I sympathize with that. and at the same time we went and talked to neurosurgeons and we were told we don't care we're making a whole we might as well make them large so we and so we essentially had these two different viewpoints that basically said doesn't matter how small you make them what that led me to focus instead is thinking well where else in the body do we have this huge population of neurons that we might actually be able to target for therapeutic purposes and that led us to the gut And so colloquially, the gut is known in our field as the quote-unquote little brain.
5:40It has the second largest number of neurons in our body after our brain. And essentially, you can disconnect these neurons from the brain, and they actually, your gut can still function. You can still digest things. You can still, you don't feel hungry quite as well or feel full. Some of that feedback is lost, but at least the gut is able to function entirely with its own little brain. From an engineering standpoint, that's also really attractive to us because all of a sudden there is no hole. right? We swallow pills every day for therapeutic purposes, and those pills basically come into contact with the gut lining, which has all the neurons.
6:13And so we thought maybe that's one way that we could actually get at these neurons. Very clever. Thank you. Tom, your first experience of a patient with locked-in syndrome went on to inspire the rest of your work. Could you tell me a bit about that? Yeah, so I work in the field of brain computer interfaces, BCI, implantable BCI. There's a very famous company you've probably heard of. We're a famous entrepreneur driving this field forward, but we've actually been doing this a little bit longer and pulling on what Khalil said, which is there are challenges with getting into the brain through a hole in the skull, partly because people don't want that, but probably more importantly because there aren't many places you can get that done and it's more invasive.
6:56So we set out on a mission to find a way to deliver electronics into the brain without disturbing the local natural architecture of the head and the body. And yeah, so in my early clinical career, in my neurology training, I had a young man around my age now, early 40s, who had a family of three, and he had a stroke. And the stroke was actually a tiny stroke in a part of the brainstem called the pons that carries all the motor fibers out of the brain. About 20 % of your brain is made up around controlling the movement of your muscles. I'm using my mouth, I'm using my body. And if you cut that fibre, then you can't control your body.
7:37But the rest of your brain is working. And it was horrific because, and that's still happening now, there's no therapy for people who have major strokes. There's no treatment for broken nervous systems. So I think the great hope with BCI is that this technology can bypass the failed body where the brain is still active. Very clever. Thank you, Tom. Eleanor, you've developed a new approach to drug delivery because the conventional pills and injections isn't super efficient. Is that right? That's right. So if you take a pill or you have an injection, you are putting the drug everywhere in your body.
8:16Your bloodstream is there to carry material around, which if it's food and oxygen is a good thing. Unfortunately, that means the amount of a drug that actually makes it to a particular target site is less than 1%. That aim might not be enough, and obviously the rest of your tissue is absorbing that drug, and with very toxic drugs, such as the use for treating cancer, that can give you very severe side effects. And one solution for that might be bubbles, right? Why are bubbles a solution? Well, that's what we're hoping. So what we're actually doing is repurposing bubbles as drug delivery systems.
8:45So these are tiny little bubbles of gas. They're about a 50th of a human hair, so they can safely go through your blood vessels. Because they are so tiny, we have to stabilise them. So they've got an outer coating of a protein or some very biocompatible material. And we use that to also encapsulate drugs. So you've got this little ball of gas. It travels through the bloodstream. The drug doesn't do anything. And then we focus the ultrasound at the target site to break the bubble open. And we release the drug just in that site. So we're hoping to get much more of the drug to the right spot and minimize the risk to the rest of the body.
9:17Okay, so the bubbles travel all the way around the body, but you just burst them at the exact right point. so you're not sort of exposing everywhere to something potentially harmful. Exactly. Very clever. Tom, your brain implant is called stentrode and it detects changes in brain activity. And like Eleanor, you're making use of our blood vessels. Could you tell me about the non-invasive way that you get this implant into people's brains? Yeah, so the motor cortex command center of the brain. The brain is pretty well understood in the way it controls movement. So if you have a small enough sensor above a certain region of the brain, there's a part that controls your mouth, part controls your hand, part controls your foot, part controls various parts of your body.
9:59So if you have a sensor over that part of the brain, you see the brain looks like a lightning storm in voltage potential. So it's electrical activity in the brain. So detected with a voltage sensor, you can then train an algorithm to know that, oh, in that moment you're trying to, say, open and close your hand. Once you've trained an algorithm on that, you can then pull it out and send commands, like through Bluetooth, to a system that would push a cursor around a screen or make selections on a screen. Everyone knows what it feels like to lose your phone. You suddenly become incapacitated. When you become paralysed, you become very dependent on other people.
10:35So we're trying to use the technology and able to restore that independence in their life. How do you do that in a not very invasive way? Because sort of instinctively hearing, device in a vein on the top of your brain, that sounds like it's going to be pretty invasive. What's the way that you insert it? So our first generation is just targeting the safest, largest, most accessible blood vessel, which is called the superior sagittal sinus, the one running down the middle. And so we're kind of almost like dropping satellites in the blood vessels to create telecommunication systems inside the brain.
11:10But you don't have to put the device sort of directly through the skull, do you? You can go through a different part of the body, is that right? Yeah, so we enter the jugular vein in the neck, thread the device up through a catheter, and then connect the lead that's coming out of the neck to a device that looks like a pacemaker box that sits under the skin in the chest and communicates the brain information out of the body. I've heard you call it the back door of the brain. Well, there's this field of neurointervention being pioneered. It's quite new in medicine and in fact there's been a breakthrough in the last 10 years that has meant that if you have a stroke and you need to get the blood clot out of your brain that's caused the stroke you can now have that therapy done through a catheter that's fed up into the brain.
11:53So that has exploded over the last 10 years and incredibly the most effective therapy for stroke ever but what that's now created is a whole many thousands of people who can now perform these procedures. And so this is exactly what happened through the 70s and 80s with cardiac medicine for treating heart disease with stents, treating valves now that previously required open heart surgery. That kind of revolution took a while to come to the brain, but now it's coming to the brain. And I think BCI is going to be the first demonstration that you can use those techniques to deliver sensors in a way that is attractive for scale.
12:29And by BCI, you mean brain computer interface. Great, thank you. And Kilil, if Tom used the backdoor to the brain, your way is sort of similarly surprising. Could you tell me a bit about the early experiments which showed potential for influencing the brain via the digestive system? Electricity is not new. In the 60s and 70s, after cardiac pacemakers became quite successful, and scientists were all excited about where else could they put these electrical stimulators. And they targeted a specific disease called gastroparesis. So gastroparesis is delayed gastric emptying. Basically, your stomach is not pumping enough.
13:07And so they said, well, if we can make the heart pump, maybe we could make the stomach pump. And they did it. And repeatedly since then, we have found that it does not do anything, that it does not make the stomach pump faster. However, it makes people feel better. And when I say feel better, it means they were reporting lower symptoms of nausea and vomiting. and both of those are sort of neural mediated symptoms. There's a tiny zone in our brain that basically regulates that. For us, it was interesting because we said, well, maybe instead of having a whole pacemaker implanted that could elicit this effect, maybe we could do it through a pill.
13:44The difference is kind of significant because you're basically talking about targeting the same tissue but from different sides. So if you go on the inside, you have your sort of mucosal surface. Things are kind of dirty in there. If you go in surgically, you get to the muscular side. And so we did a series of early experiments, and we started just zapping little pieces of stomach, and then we looked at blood levels of different GI hormones. And the one that popped out really interestingly was this robust increase in a hormone called ghrelin. So ghrelin is a hunger-promoting hormone. The minute you take a bite of something, it tanks all the way to zero, and then as you get hungrier and hungrier, more time has elapsed since your last meal, ghrelin goes up telling you to go eat.
14:23we were able to deliver the stimulus to the stomach and get repeated and robust increases in the short term of this hormone gradum which was really you know i think validating some of our approach and so that led you to create your pill your little device called flash so what's it look like could you kind of paint a bit of a picture for us yeah so if you uh i'm sure some people in the audience take supplements if any of you take your omega-3 capsules you think of it as about that size, but instead of containing chemicals, it contains electronics. And so on the outside are circumferentially wound electrodes, basically tiny metal wires.
15:00And inside we have a battery, some electronics to basically shape what the pulse that you receive. They're like micro zaps that you basically can't feel. You swallow this, it has about enough energy to stimulate for about 30 minutes, and then it passes along its way. I mean, it's very impressive. It's really small. And I hear it sort of ran into some problems with the fluid in the gut. Is that right? And you found a solution in an Australian lizard? So our gut is disgusting. Let's just put it that way. Our stomach is basically this vat of acid that constantly has little levels of fluid. Sometimes it has solids.
15:39Even in the fasting state, the stomach constantly is secreting fluid. And so you have this little puddle of acid that sits at the bottom of the stomach. And after you swallow a pill, this pill ends up in that little puddle. And if anybody knows the old advice of never touch electricity after a shower, you know that water and electricity shouldn't necessarily go together. Water is a fantastic conductor. So that was the main problem that we were getting initially, is that the water was shunting away a lot of the electrical stimuli, and it wasn't actually going into the tissue. And so nature has figured out a lot of our problems.
16:14we essentially found this really interesting creature. It's a lizard that lives in the arid deserts of Australia and it's what's called the thorny lizard. Its skin actually has a bunch of grooves and what these grooves do is that they allow it to wick water up from the basically the surface of the sand where their paws are all the way up to their mouth. So it doesn't actually have to go down and drink it basically just kind of aspirates whatever water is there into the mouth And so this really was inspiring for us because it was an example of how can you channel water in ways that don't require active pumping or active energy, delivering basically the water to where it needs to go and away from the surface between the electrodes and the tissue.
16:57That's fascinating inspiration. And Eleanor, you were tasked with including oxygen in the bubbles which you're using to deliver drugs. Why is oxygen important and why was that such a challenge? One of the challenges, actually in a lot of diseases, but cancer particularly, is because tumours grow very quickly, you end up with a rubbish blood supply. There aren't enough blood vessels in the tumour. And so areas get completely starved of oxygen. And the problem when you starve cells of oxygen is they start behaving very strangely. They start going effectively into a zombie state. And it's very, very difficult to kill them.
17:29So drugs don't work. Radiotherapy doesn't work. Our own immune system can't kill these cancer cells. So if we could deliver oxygen simultaneously with the drug, we could temporarily reverse that and hopefully make the cancer cells easier to kill. That's sort of counterintuitive because in a way you're sort of trying to boost the cancer cells, wake them up in order to fight them. Yes, exactly. So the reason it's difficult is that oxygen is a very, very small molecule. It's very soluble. We have a very, very good way throughout the body of distributing it, which is exactly the opposite from the types of gas we usually put in our bubbles.
18:02We usually something incredibly inert, incredibly heavy that isn't going to go anywhere. When we were asked by my colleagues who developed the drugs that we're working with, they said, oh, could you put oxygen in the bubbles? I went, yeah, no problem. I gave my poor PhD student many months of misery in the laboratory as we desperately tried to keep this gas inside our bubbles, and every time we made them, they just fell apart immediately. That's so interesting, because you'd think putting oxygen in a bubble is easier than putting some complex drug in a bubble, but that's actually where things got really difficult.
18:33Yeah, and luckily after many months and a lot of brainstorming in the entire team, we figured out, well, right, we need to completely change the coating. We've got to make it much more gas-tight, so we keep that. And actually, in the end, what we started doing was making the bubbles the old way with our very heavy gas and then partially substituting it with the oxygen. And actually, it turned out the gas we've been using is a really, really good solubiliser of oxygen, and it was holding it all together. When you say make the bubbles, what exactly are you doing? I was worried you were going to ask me that.
19:05It's embarrassingly simple. If you've seen a cappuccino machine, it's very similar. We sometimes use a bit of ultrasound to shake it harder. That's the best way to make lots of bubbles very quickly. At the other end of the spectrum, if we need to make bubbles very precisely, we can use microfluidics, but then you are literally making bubbles one by one. It's not a great way. More time-consuming. Yeah. Tom, your team became the first in the world to receive approval for human trials of a permanently implanted brain-computer interface. And as you mentioned, it's embedded in a single vein. How does that device record brain activity?
19:43What exactly is it looking for? The system turns on after the implant, and we go through a training paradigm where you have to move different parts of your body. You basically map the body. You then say, well, what's the minimum amount of input needed to, say, control your phone. And basically, you can get around your phone with basic levels of directional control, up, down, left, right, menu, select. So that's what we do. Could you give me an example of a patient that you've worked with and what you've been able to do with them? It's been a journey of different users doing different things. Rodney has most recently been, as well as Mark in Pittsburgh, has been using the latest Bluetooth profile, which we have worked on with Apple, which is actually, I think, being released this week, a new HID, Human Interface Device, which is a language for Bluetooth.
20:42So there's an HID for a keyboard. There's an HID for a mouse. There's an HID for an eye-tracking system. There's now going to be an HID Bluetooth for brain control. Up to this point, we've been tricking the computer into thinking the brain signals coming in were coming from a keyboard or a mouse, now we have an ability to build different features that are truly brain-derived. Thank you, Tom. This is The Engineers, exploring the human from the BBC World Service. We'll be talking about the future of biomedicine and its social impact later. But first, audience, it's your turn. Does anyone have a question about something that we've discussed so far?
21:19Okay, we've got quite a few hands. Let's start with the lady in the middle, slightly to the left with the blue top hello my name is Cheryl um I would like to know if with the bubbles you've targeted them at other cells in the body besides cancer ones Eleanor I think that's one for you um yes we're increasingly looking at treating stroke um so actually delivering the drugs that are clot busting because those are also horribly horribly toxic um and we've got a big project on delivering antibiotics um because again antibiotics are fantastic but they wipe out all the bacteria in your body and most of the bacteria in our body are really really important and really useful so if we can target that delivery so hopefully next year we're actually going to be trialing this in chronic wounds with antibiotics anyone got a question for Khalil or Tom the lady there and then the person over here on the left thank you thank you very much my name is Rushi um it's a question for Khalil you've got the pills presuming you recover them as they come out do you foresee a time when you're they're going to be able to be dissolved in some way or something like that Yeah, it's my favorite question.
22:27Yes, retrieval is a problem. So right now, most of the electronics that we have are very much inorganic materials that don't necessarily degrade very well in the body, and essentially you either have to retrieve them or flush them down the toilet. And so that obviously poses issues, especially when you think about scaling up. There's a sort of parallel push towards making electronics that are not just ingestible but edible. And so there you are trying to sort of make these same tools, but from food grade materials. And so you can imagine how that is a lot more conducive to what you're describing.
23:03Right now, those two fields are starting to talk to each other. Great. Thank you. And next question. Hello. You mentioned that everyone has the same brain part for left arm, right arm. But is there like an auto tune for like running and walking stuff you don't realize you're doing? Is that similar across everyone? Yeah, the auto-tune happens often at the spinal cord level, actually. There's embedded, I mean, you were talking about the gut having its own mini-brain. The spinal cord has a range of, like, you can, you know, I think in five years we'll have domestic robots in our houses. And so we've been thinking what it might mean to have one of our users controlling a domestic robot.
23:41And initially you think, oh, well, you'd have it controlling its arms. Well, actually, no, you probably wouldn't. You'd have it controlling higher orders of goal setting, cognitive goal settings. Yeah, it's going to you'd always stay at the at the goal level. In fact, every domain of the brain is has got some goal. There's an inherent thing that you want to do that the brain is trying to achieve for you. Thank you so much for your questions. We must take a short pause. We'll be back shortly to find out more about pioneering biomedicine. You're listening to the documentary from the BBC World Service.
Read the full transcript
24:17With the new Schwab Teen Investor account, teens can gain hands-on investing experience and build positive money habits. It's an account co-owned by you and your teen, so you can monitor and engage with the account while your teen learns how to invest and manage money. Learn more at schwab.com. Before Achilles found glory and Odysseus eventually found his way home, someone had to compose the Iliad and Odyssey. But was their credited author, Homer, even real. Hi, I'm Greg Jenner, host of You're Dead to Me, the comedy show that takes history seriously. And we are travelling back to 8th century BCE to trace the origins of the Iliad and Odyssey, epic poems that became backbones of Western literature.
24:59Join me and my fantastic guests as we unpack the stories of ancient Greek culture, war and triumph and have a laugh while we do it. Listen on BBC.com or wherever you get your podcasts. Thank you. Bye.
25:14I'm Caroline Steele and this is the Engineers Exploring the Huben. I'm joined by three world-leading engineers in the field of bioengineering. Tom Oxley is professorial fellow at Melbourne Medical School and CEO of Synchron. Eleanor Stride, OBE, is professor of biomaterials at the University of Oxford. And Khalil Ramadi is assistant professor of bioengineering at New York University and head of the Ramadi Lab in Abu Dhabi.
25:47Eleanor, your bubble technology is going to human trials in October. What are you hoping for? That's the plan. This is subject to paperwork, as always. We have tested the safety of the bubbles already, so we're fairly confident. But this will be the first time, actually, with a chemotherapy drug. So we're going to be looking just to triple check that, first of all, no one to all defects. and then we are actually quantifying the amount of drug we've managed to deliver. So this will be in breast cancer, so these are patients who are going to have surgery anyway, so we'll take the tumours out and actually quantify whether we have succeeded in delivering more drug and hopefully whether that's led to more cancer cell death.
26:27So that's, fingers crossed. All clinical trials, the first number one is safety, so that's really the primary outcome for us. It's very exciting and could save many, many lives. how far off this being available to the general public do you think we are? This is a super question. So I think 15 years ago I thought we were five years away. At least now the gap is closing. So you do your first trial, it's a small number of patients, fingers crossed, everything goes well. You then have to go to phase two and then you have to go to phase three and the number of patients and the cost and the time increases.
27:03after that, provided everything has gone well and everything has worked sufficiently well, that's when you would then apply to get it approved for the NHS or in different healthcare. So we're probably looking at 10 years. Another 10 years. Okay, great. Thank you very much. Khalil, your invention is slightly less far along, but the implications of it could be huge. Could you tell me a little bit about the different conditions that this pill could be used to treat? So the gut is this fascinating organ that so many other organ systems overlap in. We have our metabolic system, our endocrine system, our hunger and satiety system, our immune system.
27:43And so what that means from a disease implication, it means that if we look at the stomach, for example, that's the primary organ which relays hunger, as you heard earlier, to the brain. And so different conditions, different eating disorders, potentially obesity, those are all sort of indications that we are looking at. You know, Zempick, watch out. If you go a little bit further down in the gut, you get to the small intestine. That's a little more where metabolism happens. And so there, indications potentially, like diabetes, become slightly more relevant. Obviously, super complex disease. It's not as simple as I'm describing it.
28:20But these are the types of circuits that we have in our body and where they overlap. And then the colon, if you look a little further down, that's where water regulation happens. There are some studies to show that you can sort of boost immunity one way or the other, depending on if you want to tone down inflammation or if you want to sort of upregulate the immune system, put it on hyper alert. And so depending on where we go, I think the indications are a little varied. Thank you. Tom, so far we've focused on how stentrode can help with conditions like locked-in syndrome. What are the other possibilities for it?
28:54Where do you see stentrode going in the future? So if the first wave of implantable BCIs is in the domain of motor control, then the spectrum of conditions that cause motor impairment could potentially benefit. So neurodegeneration, motor neuron disease, stroke, multiple sclerosis, cerebral palsy, spinal cord injury, head injury, severe arthritis. There are many conditions that stop you being able to engage in the physical and technological world. So I think the first wave of motor system devices will affect that. that but I think as the technology moves towards other cortical domains it will move into the domain of speech into the domain of vision hearing and then what I think is really interesting is emotion emotional content so a lot of a large portion of your frontal lobe is made up of reacting to the world what annoys you what makes you happy what frustrates you all those emotions that are embedded in non-verbal communication.
29:59The brain takes up a surprising amount of neuronal activity controlling that unspoken language. And there are many conditions such as autism and many others where the challenge of communicating your emotional state could potentially, this technology could really help. So with emotions, could it get to a stage where maybe I'm feeling frustrated but finding it hard to articulate it, there might be a way of sort of getting that feeling out of my body and communicating it to someone else. That's exactly what I think will happen. And, you know, maybe you don't want that, where maybe you don't want your partner or knowing, or maybe they're having trouble picking it up.
30:41But I think if you're engaging with technology that is now physically able, which I think is coming in the next five to 10 years, then it could be really important that that technology knows how you feel in that moment. So maybe you're having small emotional reactions and the technology is reacting around you. I can't tell if that's going to solve or cause lots of arguments. Definitely one of the two. Eleanor, we've talked a lot about chemotherapy, but do you see your bubbles helping with other areas of medicine? Absolutely. So I think I mentioned earlier, antimicrobial resistance is a really, really terrifying problem that we need to do something about quickly overuse of antibiotics is one of those problems so if we can target the antibiotics much more effectively or we can use other drugs hopefully we can reduce the acceleration of resistance that we're seeing because at the moment we give antibiotics far far too much to humans and to animals so if we can find a way of targeting it that would be great the other sort of allied challenge with bacterial infections is bacteria grow these horrible things called biofilms so if you scrape your teeth it's the horrible goo that comes off on your fingernail bacteria live in these biofilms and it's really hard to get the drugs into them to actually kill them off so again using the bubbles you get this mechanical effect you can actually break up the biofilm to get the drug into the bacteria and kill them as well so that's something we're very excited about and say we're hopefully testing this next year so fingers crossed fingers crossed tom you must be aware of the ethical issues with interpreting people's brain waves i mean a large proportion of the population already think that we have microchips in our brains.
32:15How do you deal with those ethical concerns? I think about this a lot. I think there are concerns. The first thing I'll say, so, and I think about things in three principles, privacy, autonomy, and discrimination. The first thing I'll say on privacy, if anyone's watched Black Mirror, I think it's that the Brits are to blame for Black mirror. The dystopic narrative on where BCI goes in society has some elements of truth to it. I think it's on a long horizon, but the irony around the privacy concern with BCI is that the people in need right now have the exact opposite requirement. If you become paralyzed, you lose your privacy because you now become dependent on someone else.
33:02And that's ironically what they're looking for. So you have to give up your brain access to enable this. But in a future state, the question becomes, well, how do you, especially if you move into the domain of subconscious engagement, if it starts to engage with things that your brain is doing at a subconscious level. So I think if that happens, then there's a real question around how you handle privacy and consent, and you're starting to give up what could be very intricate parts of yourself. So I think that's a major consideration and there has to be agency and sovereignty to the systems. And when you say BCI system, just to clarify, you're referring to part of, you're partly referring to the device that you're implanting into people's brains.
33:45I'm talking about a situation where you have a implant and it's able to understand some of your cognitive processes and it's engaging with layers of technology around you. okay that makes sense and just back to that black mirror episode which i've seen there are examples where something goes something small goes wrong in someone's brain but it has hugely devastating consequences and they have a chip put into their brain i guess not massively dissimilar to what you're doing tom and it is able to completely transform their brains and um people are able to liver's normal after having had a stroke or something like that.
34:24But the issue is people become reliant on a technology that they don't have total control over. And I guess this is probably something that you're considering. You're going to have people dependent on this technology. What safeguarding is in place? How do you ensure that they're still able to use it in five, ten years' time? So this issue has come up over several decades in other medical device applications. The first one was probably the cardiac pacemaker, which in the 70s and 80s, when it first appeared, needed multiple iterations and needed lots of support. Probably more recently, there was a widely reported company that was doing a cortical vision implant.
35:05And the company, for whatever reason, wasn't able to continue and people were left with implants that were no longer supported. So it's a challenging issue, given that the companies emerging are not government-funded. They're companies that are having to stand on their own two feet and create successful businesses. There is the risk that the companies no longer exist. So there's no easy solution. When we consent people, we talk about it. So we talk about it in the consent. Probably an important thing to mention is that you offer a certain level of functioning and then if there are upgrades, well, what happens then?
35:47How do you continue to upgrade? It's challenging to upgrade systems that have been implanted in the body. What matters is that at the moment in time, you've talked about the user that you're offering a level of performance that is better than what they had before. Now, yes, things are going to keep getting better in front of you, but that's an aspect of life that's unavoidable. But we have that conversation. and what's been extremely humbling and inspiring is that most of the people we've worked with have a life-threatening disease, mostly motor neuron disease and their motivation to do this is the belief that they're going to have made a contribution to a system that's going to help people after them.
36:29And you mentioned discrimination. Could you tell me a little bit more about that concern? So discrimination, I think in a future state, if the technology... I heard Alex Wang, the scale AI, last week made a comment that he didn't want to have children until they could get an implantable BCI because otherwise they'll be disadvantaged. And Steve Bannon has been talking about this a little bit when he's referenced Neuralink, that in the future the question is, will there be a subclass of humans, not a subclass, a different class of humans that have elected to take a technology for the purpose of augmentation and does that mean they can then participate in society at a level superior, in some way advantageous relative to not, and what will that mean for society?
37:19Great, thank you. Khalil, one last question from me. How would you feel if your pill went on to be used as an appetite suppressant, as something to help people lose weight as its primary function? That is a mechanism that we would love to be able to identify, because right now we can do the opposite. And I think... To make us really hungry. You get it. It would be great if we could suppress appetite. The biology is not so simple. And we have some hypotheses about maybe how we might activate certain appetite-suppressing circuitry. We're not quite there yet, although some preliminary data looks promising, so we'll see.
38:03But I do think that that's probably the biggest indication that we might be able to have this work for. Thank you. This is The Engineers, exploring the human from the BBC World Service. We've discussed bubble drug delivery, brain implants for communication, and electrical pills which tackle disease from the gut. It's the turn of our audience again. Who has a question on anything we've discussed so far? We've got a question down here at the front. Hi, my name's Tim. It's a general question, really. We've heard a lot in the last 12 months about the exponential growth in artificial intelligence. And I just wanted to pose the question to the three experts in turn.
38:45To what extent do you think AI will have a positive impact on your relative areas of research, or possibly even a negative one? So we'll have really quick, short, snappy answers from everyone, if that's okay, starting with Eleanor. So I think a very positive area is in rapid diagnosis. So I think in being able to process lots and lots of medical images very quickly, very efficiently, the radiographers don't get tired, we can detect diseases earlier, we can treat them much more effectively, I think that's where. The problem with all AI, if you don't have good data, and you are using the wrong statistical processing, you will get rubbish answers and that's I think where the danger lies so we've just got to be super careful where we apply it.
39:27Tom next. In the good instance integration with AI and BCI is in a sense needed because the ability to make sense of the huge amount of data in the brain will be best served by AI and it will enable interaction between brain activity and technology but on the flip side, from what we've already seen, the algorithms that start to please humans from a corporate commercial perspective have already playing on human systems that are very vulnerable and they're primarily dopaminergic because they're addictive. So what I worry about is how that plays out over time. And finally, Khalil. I'm going to answer your question very practically, which is that as a researcher, these LLMs are fantastic for exploring ideas, drafting things, and I think it's very much changing the way that researchers sort of start to generate ideas and collectively brainstorm.
40:23So I think that's sort of a really positive one. Negative is that maybe we'll all end up having the same ideas. I don't know. I think Eleanor has something she wants to add. I think another thing we also need to be crucially aware of is just how much energy these things take. So again, in being very careful what we apply them to because they consume electricity and water like nothing we've had on the planet. Any more questions? So we'll start with the man over here in the aisle and then afterwards we'll go to the lady at the back. Thank you. As someone that lives with left front lobe epilepsy, the delivery of drugs you've always put with the brain and the gut, is there a correlation between between implants, bubble, and the gut.
41:04Could the three work together? Is this a moment for a collaboration? What do you think? Who wants to take this one? Khalil? Could we work together? Absolutely. I think the, I mean, we met each other a few hours ago, just full disclosure here. And let's just say time flew by, just in terms of when you put geeks together, we just end up having interesting conversations. I don't want to speak for sort of all engineers, but I will say that one thing that really excites me is where there is a problem that is unsolved. And I think that's sort of just kind of the engineering hat. So most of the projects that we embark on start off with what is a problem that is currently underserved or where there is an opportunity to have an impact.
41:50And then do we think that we have a novel enough idea to actually think that we can make an impact? Thank you. And we're going to go to the lady in the centre here. Hello, this is a question for Eleanor. What happens to the bubbles and the drugs inside them that aren't burst when they're targeted at the target organ? Thank you. No, it's a very good question. So the gas eventually just leaks out and you're left with a tiny little crumpled balloon, essentially, which gets processed by the liver. Now, that does mean not all of the drug is getting to the target. it there are two things we have to take into account there first of all we are typically using a hundred times less drug than you would normally give systemically so that the risk of side effects is still quite substantially reduced um the other thing though is we try and engineer the coating so the drug stays passivated it doesn't do anything and it's passed out so hopefully that's that's a way of dealing with that great thank you next question hi there panel um primarily for tom There's been a lot of discussion about the use of the implants for treating these degenerative diseases.
42:58Is there any way there could be potential for tracking onset and worsening of the conditions? The use of the implants for diagnostic purposes is fascinating. Lots of potential, especially in epilepsy. The challenge is that they're very expensive and they've got risk. So the field of diagnostics, especially with a permanent implant, you've got a very high burden for justification for putting it in. I think probably one of the most compelling areas that is emerging is in the domain of epileptic seizure cycle detection. Because otherwise, neurologists have very little way of understanding when seizures are happening, apart from the patient recounting, but the seizure makes you lose memory.
43:47So there is no mechanism right now of knowing when your brain is going into abnormal patterns or not, and that can inform therapy. Thank you. I see a few young faces in the audience. Does any one of our younger members want to ask a question? There's someone keen over there in the back wearing a hoodie. This is quite a lighthearted question, but could you use neural implants to do more realistic VR gaming? Oh, good question.
44:19I think that'll be one of the first groups that are early adopters for this technology. I'm not joking. And I think the reason it's going to be attractive is... And it's, by the way, US defence... That's why US defence is interested, because you can engage with systems in a more responsive way than what your body can. So you get down your reaction times for technology control. So gamers, maybe. What interest has it been from US defence? Tell me a little bit more about that. Well, actually, the field of BCI started with several hundred millions of dollars from US defence from DARPA. That was where our first funding came from.
45:00Then over the course of 10 to 15 years, that funding went away. Trump came in and there was more of a focus on soldiers, weapons. So there's less investment now from US defence. but there's been the initial defence interest was helping people who were coming back from desert warfare who'd lost arms, legs and arms, to restore control of prosthetic limbs and then also to understand post-traumatic stress from head injuries. So that's the origin. Thank you very much. Fantastic question. Thank you. Gentleman there. Hi, I'm Michael of Laherty. It's a question about engineering, really. Swallowing in a battery is never a good idea.
45:38Have you looked at alternative sources of energy to power your capsule? Yeah, great question. Swallowing a battery, for the record, is not a good idea. I don't recommend... Do not try that at home. I absolutely agree with that. We encapsulate it. That's why it's okay. But I think the two options that you have otherwise are you either generate the power locally or you deliver it wirelessly. Wireless powering, if anyone has obviously used it to charge your phones, you know that it's really good up close, but the minute you go more than a few centimeters away, it doesn't work. As that gets better, that could be an option.
46:11And then obviously the body has tons of sources of energy too. You have chemistry, so you can play around with local ions and acids. You can harvest mechanical energy. The catch there is that if you take the energy out of a contraction, then the contraction doesn't actually do its effect. So there's a sweet spot there as well. But yes, I mean, I think you bring up a fantastic point. There's a couple of different options. I think as our colleagues in electronics and electrical engineering also get better at powering things, so too will some of the options we have available to us. Great, thank you.
46:42Next question. Thank you. And does your work with BCIs be a very small step towards a world of Terminator?
47:00Terminator was robots walking around controlled by Skynet, which is a little bit different to a human system that has an electronics implant. So, no. Let's rephrase the question. Would it set up a world where you have computer-controlled humans versus your regular biological human. Yes, you could see someone maybe being at a disadvantage if you're not one of the people with this implant. So just to make the point, the idea is to send the control of the brain out, not to have the control coming in. So there's that. But I think we're already in a world where computers are beginning to control us.
47:49TikTok is an example of an algorithm that is very addictive, that has a huge influence on culture in a not always positive way. I believe that BCIs will enable understandings of ourselves better than what we have right now. So my hope is that actually this technology helps us become more human. Great, thank you. Khalil, similar to that, could you see your pill ever being used for nefarious purposes? I think, as with all medicines or technologies that we have, there's always sort of the security component. It can be as simple as counterfeit medications that are labeled in one way but in fact carry something else.
48:32And the minute you introduce electronics which are, let's just say, adaptable after they are manufactured, I think that also opens the door towards active manipulation as opposed to just source manufacturing manipulation. So yes, I mean, I think security is a huge component of it. And honestly, in part, why some of these things are so expensive to develop is that you have to take all of this safety and security into account. Thank you. And yes. Hi, this is a question for Tom. I was wondering in terms of what you're most excited to experience or see coming forward from the technologies you're developing now in terms of brain interfaces and where that will develop from there.
49:14What I'm excited about on a long-term perspective is this technology, assuming it's safe and it's effective, you've got a mechanism to transmit information from the various cognitive domains of your brain. and I think in a future state this is probably a couple of decades away but if we have the device streaming from multiple domains of your brain I think we're going to realize like the you know that you can have multiple ideas going in your head you can multitask you can have parallel streams of things happening in your brain you might actually be only actively consciously working on one of them but if this technology enables streams from multiple domains of brain into various technology layers, then you could potentially be working in multiple streams of consciousness at once.
50:07Thank you. And yes, thank you very much. Hello, my name's Sarah. I'm a diagnostic radiography student. My question would be, as part of mammography in the section that we do there, would rolling out your ultrasound be something that you would look to put in within our department and something eventually we would be able to do as a routine course that we do? I promise I didn't plant her in the audience. Absolutely. And something we've been really keen to do is try to ensure we're using existing clinical ultrasound systems so that we don't have to use very high-powered devices or develop anything new.
50:46So absolutely. And the idea is this will be user-friendly and something that you see the disease, you can treat very, very quickly with the same system. Thank you. Very exciting. Thank you so much for your questions. everyone. I wish we could take more, but we are out of time. That's it for the engineers exploring the human at the Royal Geographical Society in London. I'm Caroline Steele. On behalf of the BBC World Service, our partners, the Royal Commission 1851, and my producer, Charlie Taylor, please join me in giving a warm round of applause for our pioneering engineers, Eleanor Stride, Khalil Ramadi, and Tom Oxley.
51:21Thank you very much.
51:30You've been listening to The Engineers exploring the human for the documentary from the BBC World Service.
From the publisher
Engineering has moved inside the body to innovate like never before. In neuro-science, brain implants can provide ‘psychic’ communication for people with locked-in syndrome. In medication a new technology aims to deliver chemo therapy and other drugs directly to the parts that need them by bubbles in the blood stream. And ingestible electronics are being made to fight disease by sending antibody-directing messages straight from the gut to the brain. The BBC and the Royal Commission for the Exhibition of 1851 have come together to stage a special event. Presenter Caroline Steel is joined by Tom Oxley, professorial fellow at Melbourne Medical School; Eleanor Stride, OBE, professor of Biomaterials at the University of Oxford; Khalil Ramadi, director of the Ramadi Lab for Advanced Neuro-engineering and Translational Medicine in Abu Dhabi; Assistant Professor of Bioengineering, New York University.




